| Abstrakt: |
HeartFlow Inc. has been granted a patent for a method and system that aims to improve the accuracy of data on coronary lesions and their impact on blood flow. The system involves creating a three-dimensional model of a patient's heart using patient-specific data and using a physics-based model to determine the fractional flow reserve (FFR) within the heart. The FFR is a ratio that helps assess the functional significance of coronary lesions. By optimizing the boundary conditions of the models used, the system aims to enhance diagnosis and treatment planning for patients with suspected coronary artery disease. This article provides fact-based news on research and discoveries in the field of cardiovascular health, covering topics such as angiology, perfusion, cardiology, chest pain, myocardium, hemodynamics, heart disease, blood pressure, heart research, and diagnostics. It mentions HeartFlow Inc. [Extracted from the article] |
